by the biopharmaceutical industry stood at 65.2bn in 2008. ref cite web author BriskFox Financial title Biopharmaceutical sector sees rising R&D despite credit crunch, finds analysis url http www.briskfox.com open years 2009 q1 do v c44751.php accessdate 2009 03 11 ref When a biopharmaceutical is developed ... cost for development of the biopharmaceutical. The patent laws in the United States and Europe differ ... there were 34,527 patent applications. ref cite web author Luke Foster title Patenting in the Biopharmaceutical ... risks and from ethical issues. Biopharmaceutical crops also represent a risk of cross ... approach to this technology is the creation of a transgenic mammal that can produce the biopharmaceutical ... more details
Nanobiopharmaceutics is an inter disciplinary field involving delivery of biopharmaceutical products through nanobiotechnology applications like nanoparticles , liposomes . It involves knowledge from nanobiotechnology , biotechnology and biopharmaceutics. See also Biopharmaceutics Nanomedicine Category Nanotechnology Category Pharmaceutical industry ar nano tech stub pharm stub ... more details
Orphan date February 2009 Primarysources date February 2011 China Biologic Products, Inc. , through its indirect majority owned subsidiary Shandong Taibang , is the only blood plasma based biopharmaceutical company approved by the government of Shandong Province , the second largest province in China with a population of 93 million. The company is engaged in research, manufacturing, and sale of plasma based biopharmaceutical products to hospitals in China hospitals and other Health care in China health care facilities in China . Plasma based human albumin is used mainly to increase blood volume while Immunoglobulin is used for disease prevention and Therapy treatment . External links http www.ctbb.com.cn Company website Category Companies based in Shandong ... more details
Orphan date February 2009 Ludger Ltd http www.ludger.com is a biotechnology company with R&D and manufacturing facilities at the Culham Science Centre, Oxford , UK ref http www.culham.org.uk news press office article detail.asp?Article ID 1010 ref . The company specialises in technology for the measurement and control of biopharmaceutical glycosylation . ref http archive.oxfordmail.net 2008 5 23 246339.html ref The company was founded in 1999 by its Chief Executive, Dr Daryl Ludger Fernandes. Dr Fernandes had developed glycoprofiling technology for his doctorate in the Glycobiology Institute at the University of Oxford and in the late 1980s was responsible for transfer of that technology to Oxford GlycoSciences OGS . In 2000, the company won a UK Department of Trade and Industry United Kingdom Department of Trade and Industry DTI Smart award to develop biopharmaceutical glycoanalysis technology. ref http archive.oxfordmail.net 2000 4 17 78650.html ref in 2001, it won a UK DTI Link grant for a collaborative R&D project to develop rapid glycoanalysis technology with GlaxoSmithKline and the University of Oxford. The company s focus is to provide products, services for characterization and quality control of biopharmaceutical glycosylation. Current products include kits and reagents for detailed analysis of N linked and O linked glycan s by High performance liquid chromatography HPLC and mass spectrometry . Current services include contract glycosylation analysis to support biopharmaceutical development and regulatory submissions to the U.S. Food and Drug Administration and European Medicines Agency , glycoprofiling method development, and training in biopharmaceutical glycoprofiling procedures. The key glycoprofiling modules include monosaccharide analysis, sialic acid analysis to determine relative levels of human vs non human sialylation, oligosaccharide profiling, and detailed glycan structure analysis. References Reflist Category Biotechnology companies of the Unit ... more details
Unreferenced date September 2008 Infobox Company company name Halozyme Therapeutics logo Image Halozyme Therapeutics Logo.gif company type Public company Public nasdaq HALO company slogan foundation 1998 location San Diego, California , United States USA key people Jonathan E. Lim , President & CEO num employees 130 industry Biopharmaceutical products Biologic s revenue profit 3,799,521 United States dollar USD 2007 homepage http www.Halozyme.com www.halozyme.com Halozyme Therapeutics , based in San Diego, California , is a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the endocrinology , oncology , dermatology and drug delivery markets. http www.halozyme.com Category Companies in the NASDAQ Biotechnology Index Category Companies based in San Diego, California ... more details
VPM may refer to Value Process Management Varying Permeability Model Vampire Princess Miyu Ventral posteromedial nucleus , a nucleus of the thalamus part of the brain. Virtual Product Management Vranken Pommery Monopole Variation Point Modeling Computer science Vakzine Projekt Management GmbH, a private vaccine and biopharmaceutical development company in Hanover, Germany Long comment to prevent listing on Special Shortpages.......................................................................... disambig de VPM it VPM ... more details
Unreferenced stub auto yes date December 2009 The biopharmacology is the branch of pharmacology that studies the use of biotechnology biotechnologic originated drug s biopharmaceutical s . See also Pharming genetics Pharming Category Biotechnology Category Pharmacology Biotech stub ar ca Biofarmacologia de Pharmazeutische Biotechnologie es biofarmacolog a ru sl Farmacevtska biotehnologija ... more details
Basilea is the Italian language Italian and Romansh language Romansh name for Basel , Switzerland s third most populous city. Basilea may also refer to 2033 Basilea , a main belt asteroid Basilea Pharmaceutica , a Switzerland based biopharmaceutical company Basilea Schlink 1904 2001 , German religious leader disambig Category Given names de Basilea it Basilea disambigua ... more details
Infobox company company name Zistdaru Danesh Ltd. company logo Image Zistdaru danesh.jpg 110px location Tehran , Iran products Biopharmaceutical s homepage http www.zistdaru.ir Home.html www.zistdaru.ir Zistdaru Danesh Ltd. also Zist Daru Danesh Ltd. is a private pharmaceutical company which is located in the Pharmaceutical Incubator of the Tehran University of Medical Sciences and is active in the development, manufacturing and marketing of biopharmaceutical s. The company is one of the leading manufacturer of biosimilar products in Iran. ref http www.zistdaru.ir Home.html Zistdaru Danesh Co. Ltd. ref Zistdaru Danesh is manufacturer of the active pharmaceutical ingredient of interferon beta 1b which has been marketed as ZIFERON . interferon beta 1b has been approved to treat relapsing remitting and secondary progressive multiple sclerosis using a 8 million units 250 micrograms vial on alternate days by subcutaneous injection. ref cite news title Iran Starts Mass Production of MS Drug url http english.farsnews.com newstext.php?nn 8906280807 date 2010 09 19 ref ref cite news title Iran Starts Mass Production of MS Drug url http www.presstv.ir detail 143010.html date 2010 09 18 ref References reflist External links http www.zistdaru.ir Home.html Zistdaru Danesh See also Interferon beta 1b Interferon ZIFERON Category Health Category Schools of medicine in Iran fa ... more details
Image BPSA Logo Only Outline.jpg thumb right 200px Logo of the Bio Process Systems Alliance. The Bio Process Systems Alliance BPSA is a biopharmaceutical industry trade group of suppliers of single use components and single use systems for manufacturing processes. It was created in 2006 through an alliance of 26 suppliers. References cite news first Denise last DeTommaso title Disposables Pushing on an Open Door publisher Pharmaceutical Processing pages 8&ndash 9 date April 2006 Category Trade associations business org stub ... more details
Unreferenced auto yes date December 2009 Orphan date February 2009 Ultraz is a Fluoroelastomeric compound developed by Aquasyn specifically for the Biopharmaceutical industry. A base resistant compound with excellent steam resistance, Ultraz performance far exceeds the baselines of EPDM or PTFE. It is typically used as a membrane material in Hygienic Diaphragm Valves . In Biological applications with periodic steam sterilization requirements, Ultraz is the optimal material for the combined temperature resistance of PTFE and the flexibility of EPDM. USP class VI, cytotoxicity and heavy metals tests have been performed with its use in industry for almost ten years. It is low protein binding, flexible and temperature resistant. Category Fluoropolymers Chemistry stub ... more details
wiktionarypar regulon Regulon may refer to TOC right Science, technology, and mathematics In cell biology and genetics , a regulon is a collection of genes or operon operons under regulation by the same regulatory protein . This term is generally used for prokaryote prokaryotic systems, for example quorum sensing in bacteria . It is a group of operons genes spread around the chromosome but controlled by a common factor or stimulus. Multiple regulons can form a modulon . Regulon, Inc. biopharmaceutical company based in Athens, Greece and in Mountain View, CA USA http regulon.org http regulon.org Official Site Other uses Regulon was the sad, homosexual, emperor of the universe portrayed in the novel Regulator of the Universe , by the underground Japanese author Pen Nam. disambig ... more details
Infobox Company company type Public company Public company name Unigene Laboratories foundation 1980 key people Warren Levy, president & CEO br James Gilligan, vice president, product development industry Biotechnology num employees 85 2007 homepage http www.unigene.com Unigene Laboratories OTC UGNE is a biopharmaceutical company, engaged in the research and development of peptides for medical purposes. The company was founded in 1980 and is located in New Jersey. The company s primary focus is on the development of calcitonin and related peptides for the treatment of osteoporosis . The company has licensed worldwide rights to its oral parathyroid hormone PTH to GlaxoSmithKline . External links http www.unigene.com Corporate website Category Biotechnology companies ... more details
Goodwin Biotechnology, Inc. GBI , based in Plantation, Florida , is a Contract manufacturer contract manufacturing organization CMOs serving the biopharmaceutical industry. Originally spun out of the Goodwin Institute for Cancer Research in 1992, GBI s focus has been on the manufacture of pre clinical, clinical Ph I II III and Licensed therapeutic biological products. In 2004, GBI was acquired by Indian pharmaceutical company , Wallace Pharmaceuticals Pvt. Ltd. based in Goa Goa, India . Wallace is a solid dosage formulations company. External resources http www.goodwinbio.com Official website Category Companies based in Goa Category Biotechnology companies of India biotech stub ar ... more details
Medicago Inc. TSX MDG Quebec City , Quebec , Canada is a publicly traded biotechnology company focused on the development, production and commercialization of protein based biopharmaceutical s vaccines , monoclonal antibodies , biogeneric s etc by the genetic engineering of plants . Medicago is listed on the Toronto Stock Exchange under the symbol MDG . See also Plant made pharmaceuticals External links Official http www.medicago.com http irap pari.nrc cnrc.gc.ca success medicago e.html Success story NRC site Category Biotechnology companies of Canada canada company stub med company stub ... more details
Wikify date November 2010 Single Use Components are the disposable componentry used in an increasingly popular method of pharmaceutical and biologics production. They differ from traditional Biopharmaceutical process components in that they are disposed of after use as opposed to cleaned or CIP d. They can consist of disposable bag containers, tube sets, instrumentation, connectors, filters and disposable valves . Many companies have adopted this platform for its ease of adapting to new product development needs and the flexibility it allows in adjusting to varying product supply and demand. External links http www.colder.com Specialties Bioprocessing BioHome.aspx http www.artesynprocesssolutions.com Category Medical equipment ... more details
The Center of Molecular Immunology Centro de Inmunolog a Molecular or CIM , is a cancer research institution located on the west side of Havana , Cuba . Opened on December 5, 1994, it focuses on the research and production of new biopharmaceutical products for the treatment of cancer and other nontransmissible diseases. Facilities The design and construction of the Center of Molecular Immunology was modeled on current Good Manufacturing Practice guidelines recommended by the World Health Organization and adopted by Cuba, particularly those also adopted by the member countries of the European Union, then known as the European Community. Research labs, production areas and administrative offices share the 15,000 square meters of the two floor facility. Approximately 800 employees work at the CIM, most of them scientists and engineers. These personnel are administratively organized in three main areas Research and Development, Production, and Quality Assurance. Research Basic research projects are focused on cancer immunotherapy , especially the development of molecular vaccines. These include antibody engineering, cellular engineering, bioinformatics and regulation of the immune response . CIM conducts clinical trials in diagnostic imaging and cancer therapy of varying origin, as well as other immune system diseases, in highly specialized hospitals. Products Today CIM produces biopharmaceutical products, such as anti CD3 monoclonal antibody for the treatment of patients with organ transplant rejection , human recombinant erythropoietin for the treatment of anemia , granulocyte colony stimulating factor for the treatment of neutropenia , and a humanized monoclonal antibody that recognizes the epidermal growth factor receptor for cancer treatment, as well as other monoclonal antibodies for tumor imaging. Commercialization Since 1992 http www.cim.sld.cu productos ing.asp CIMAB S.A. has been devoted to the commercialization of biopharmaceutical products for the Cuba n mar ... more details
Unreferenced stub auto yes date December 2009 A bioprocess is any process that uses complete living cell biology cells or their components e.g., bacteria , enzyme s, chloroplast s to obtain desired products Transport of energy and mass is fundamental to many biological and environmental processes. Areas, from food processing to thermal design of building to biomedical devices to pollution control and global warming , require knowledge of how energy and mass can be transported through materials mass,momentum,heat transfer See also Good Manufacturing Practice Good clinical practice Adverse Drug Reaction Adverse event Assay sensitivity Biopharmaceutical networking Biotechnology Caco 2 Clinical study design Germany Category Biotechnology Med stub Biology stub ar es bioproceso ... more details
notability companies date March 2011 Sunesis Pharmaceuticals is a clinical stage biopharmaceutical company focused on the discovery, development, and commercialization of small molecular therapeutics for oncology and other unmet medical needs. The company was founded by Jim Wells pharmaceutical executive Jim Wells ref http findarticles.com p articles mi m4PRN is 2003 July 29 ai n27640059 ref , ref http cancer.ucsf.edu people wells james.php UCSF Helen Diller Family Comprehensive Cancer Center People James A. Wells, PhD Bot generated title ref . Founded in 1998, Sunesis filed and completed an IPO in 2005. It is listed on NASDAQ as SNSS. http www.shareholder.com visitors print release.cfm?releaseid 191204 External links http www.sunesis.com Sunesis Web Site References Reflist US company stub Category Biopharmaceuticals Category Oncology Category Pharmaceutical companies of the United States ... more details
Oracle Clinical or O C is a database management system designed by Oracle Corporation Oracle to provide data management, data entry and data validation functionalities to Clinical Trials process. ref cite book last Chow first Sheiu Chung title Encyclopedia of Biopharmaceutical Statistics publisher Informa Health Care date 2003 pages 397 401 url http books.google.co.uk books?id M8S8WVRUIY0C&pg PA398&dq 22Oracle Clinical 22&client firefox a PPA401,M1 isbn 0824742613 ref The Major Functions Supported by Oracle Clinical are Clinical Study Protocol Definition and Management Definition of Metadata collected during a Clinical Study. Creation of Data Entry System Creation of Data Management System to clean and reconcile Data Validation Procedures Data Loading and Extracting Thesaurus Management System for Coding Medical Terms Laboratory Reference Range Management System References references Category Oracle software ... more details
Unreferenced date March 2010 Curaxys is a biopharmaceutical company specialized in the research, development and production of biosimilar drug. The particularity of Curaxys has been the pioneer in the use of insect cell in the production of biosimilars drug. In fact, up to now the insect cell culture platform has been used for the vaccine production, and never for other therapeutical proteins . Curaxys is also developing new techcnological platform based in other expression system as bacteria , virus and yeast . The company is developing the recombinants proteins Insulin , Growth Hormone , Erythropoietin , Granulocyte Colony Stimulating Factor GCSF and the Monoclonal Antibodies Mab as Rituximab , Trastuzumab . The company is located the Technological Park of Puerto de Santa Maria, in Cadiz Spain . Other therapeutical proteins are under development as the unspecific antibodies . Category Pharmaceutical companies of Spain ... more details
Orphan date February 2009 Infobox Company company name BioImage company logo Image Logo bioimage.png company type Private foundation 1999 location Soeborg, Denmark key people Patrik Dahl n, CEO br Steven Butcher, CSO br Len Pagliaro, VP Business Development br Edwin Moses Chairman of the Board br Axel Ullrich Chairman of the Scientific Advisory Board industry Biotechnology products Products, services, and licensing around the proprietary Redistribution sup TM sup drug discovery technology revenue not available homepage http www.bioimage.com BioImage was established in 1993 as a drug discovery research unit within Novo Nordisk . The research unit was led by Ole Thastrup and spun out of Novo Nordisk in 1999. BioImage specializes in developing and selling proprietary bioassay s to biopharmaceutical companies and research institutions. It also develops bioassays on a contract service basis. BioImage has made broad patent s covering EGFP Enhanced GFP EGFP , GFP based biosensors and any genetically encoded fusion protein protein fusion to a luminophore , with subsequent monitoring of the protein s translocation within a Cell biology cell as the primary readout for drug discovery assays. This intellectual property, trademarked Redistribution, allows many collaborations and out licensing activities with biopharmaceutical companies. ref http www.bioimage.com technology.htm overview technology & applications BioImage Bot generated title ref Merger In April 2006, BioImage was acquired by Thermo Fisher Scientific . The merger was complete in November 2006, and technology transfer to a US site was completed during 2007 and 2008. ref http www.bioimage.com pdf CEOletter.pdf ref References reflist Category Companies of Denmark Category Research support companies med company stub Denmark company stub ... more details
BLP unsourced date July 2010 Orphan date February 2009 Dr. Seung Kook Park is the Managing Director of Biopharmaceutical Research Center of Hanall Pharmaceutical Co., Ltd. since May 2007. Seung Kook Park was born in 1963 in South Korea . He graduated Agricultural College, Seoul National University with a BS in 1985 and KAIST with an MS and PhD in biochemistry and molecular biology in 1987 and 1991 respectively. After one year of post doctoral training at Korea Research Institute of Bioscience and Biotechnology KRIBB , he had started his work at Research Institute of Life Science of Daewoong Pharmaceutical Co., Ltd. He was principal research scientist 1992 1995 and chief research scientist and general manager 1996 2001 . After resigning from Daewoong in 2007, he joined the Biopharmaceutical Research Centre of Hanall Pharmaceutical Co., Ltd. His was also a director of Academia Industry Cooperation of the Korean Society for Biotechnology and Bioengineering 2000 2001 and an invited research scientist at the Research Institute of Biotechnology of Takeda Chemical Co., Ltd. in Japan 1998 . He has 29 publications and 29 applied and registered patents. Awards He received a Patent Technology Award from the Korean government in 1996, a bio industry award in 2001 from the commerce minister, an industry and energy award from the Korean government in 2001, and a New Drug Development Award from the Korean Association of New Drug Development in 2003. References Reflist Persondata Metadata see Wikipedia Persondata . NAME Park, Seung Kook ALTERNATIVE NAMES SHORT DESCRIPTION DATE OF BIRTH 1963 PLACE OF BIRTH DATE OF DEATH PLACE OF DEATH DEFAULTSORT Park, Seung Kook Category 1963 births Category Living people Category Biochemists Category Seoul National University alumni ... more details
Encyclopedia
top
